Cargando…

Antidepressant drug use and future diabetes risk

Detalles Bibliográficos
Autores principales:	Kivimäki, M., Batty, G. D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2011
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228947/ https://www.ncbi.nlm.nih.gov/pubmed/22038524 http://dx.doi.org/10.1007/s00125-011-2360-9

Ejemplares similares

Commentary: Antidepressants and diabetes risk: why are there discrepant findings from cohort studies based on patient records and those based on serial phenotyping?
por: Kivimäki, Mika, et al.
Publicado: (2015)

Antidepressant Medication Use, Weight Gain, and Risk of Type 2 Diabetes: A population-based study
por: Kivimäki, Mika, et al.
Publicado: (2010)

Shift Work as a Risk Factor for Future Type 2 Diabetes: Evidence, Mechanisms, Implications, and Future Research Directions
por: Kivimäki, Mika, et al.
Publicado: (2011)

Antidepressant Medication Use and Risk of Hyperglycemia and Diabetes Mellitus—A Noncausal Association?
por: Kivimäki, Mika, et al.
Publicado: (2011)

Antidepressant Use Before and After the Diagnosis of Type 2 Diabetes: A longitudinal modeling study
por: Kivimäki, Mika, et al.
Publicado: (2010)

Risk of future depression in people who are obese but metabolically healthy: The English Longitudinal Study of Ageing
por: Hamer, Mark, et al.
Publicado: (2012)

Diabetes Risk Factors, Diabetes Risk Algorithms, and the Prediction of Future Frailty: The Whitehall II Prospective Cohort Study
por: Bouillon, Kim, et al.
Publicado: (2013)

Embarking on antidepressant response prediction using brain perfusion estimation
por: Sambataro, Fabio, et al.
Publicado: (2019)

Response Expectancy and the Response to Antidepressant Medication
por: Kirsch, Irving
Publicado: (2017)

Impact of age on optimal dose of antidepressants
por: Hashimoto, Kenji
Publicado: (2020)

Is Metabolism of (R)-Ketamine Essential for the Antidepressant Effects?
por: Chaki, Shigeyuki
Publicado: (2017)

The media and intellectuals' response to medical publications: the antidepressants' case
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2013)

Current Problems in the Research and Development of more Effective Antidepressants
Publicado: (2016)

Initiating Antidepressant Medication: What is the Most Important Factor?
por: Kasper, Siegfried
Publicado: (2022)

Does the Opioid System Block or Enhance the Antidepressant Effects of Ketamine?
por: Mathew, Sanjay J., et al.
Publicado: (2019)

Anti-obesity drugs: past, present and future
por: Rodgers, R. John, et al.
Publicado: (2012)

The future of clinical trials and drug development: 2050
por: Hardman, Timothy C, et al.
Publicado: (2023)

Sarcopenic obesity and risk of new onset depressive symptoms in older adults: English Longitudinal Study of Ageing
por: Hamer, M, et al.
Publicado: (2015)

Drug development in pediatric psychiatry: current status, future trends
por: March, John S, et al.
Publicado: (2012)

Nanophotosensitive drugs for light-based cancer therapy: what does the future hold?
por: Tang, Rui, et al.
Publicado: (2017)

Modulating sensitivity to drug-induced apoptosis: the future for chemotherapy?
por: Makin, Guy, et al.
Publicado: (2001)

Comment on Vimalananda et al. Depressive Symptoms, Antidepressant Use, and the Incidence of Diabetes in the Black Women’s Health Study. Diabetes Care 2014;37:2211–2217
por: Kivimäki, Mika, et al.
Publicado: (2015)

Comparative Effectiveness and the Future of Clinical Research in Diabetes
por: Greenfield, Sheldon
Publicado: (2013)

Back to the Future: Glomerular Hyperfiltration and the Diabetic Kidney
por: Tuttle, Katherine R.
Publicado: (2017)

A Medial Prefrontal Cortex Cell Type Necessary and Sufficient for a Rapid Antidepressant Response
por: Hare, Brendan D., et al.
Publicado: (2019)

Enhancing central noradrenergic function in depression: is there still a place for a new antidepressant?
por: Pinder, Roger M
Publicado: (2005)

Depression, suicidality and antidepressants: A coincidence?
por: Selvaraj, Vithyalakshmi, et al.
Publicado: (2010)

Against the stream: Antidepressants are not antidepressants – an alternative approach to drug action and implications for the use of antidepressants
por: Moncrieff, Joanna
Publicado: (2018)

Is the History Repeated? Can (2R,6R)-Hydroxynorketamine be Another Antidepressant?
por: Chaki, Shigeyuki, et al.
Publicado: (2018)

High-quality antidepressant prescribing: please consider whether “perfection is the enemy of progress”
por: Walkup, John T., et al.
Publicado: (2020)

Withania somnifera as a potential future drug molecule for COVID-19
por: Kashyap, Vivek K, et al.
Publicado: (2020)

Structure‐based drug discovery facilitates future painkiller development
por: Li, Yuqing, et al.
Publicado: (2022)

COVID-19 infection in Italian people with diabetes: Lessons learned for our future (an experience to be used)
por: Gentile, Sandro, et al.
Publicado: (2020)

The Nordic health registers – an important source when evaluating the safety of antidepressants during pregnancy
por: Kieler, Helle
Publicado: (2010)

Announcing the novel class of GABA–A receptor selective positive allosteric modulator antidepressants
por: Fasipe, Olumuyiwa John, et al.
Publicado: (2020)

Activation of σ1-Receptors by R-Ketamine May Enhance the Antidepressant Effect of S-Ketamine
por: Kalkman, Hans O.
Publicado: (2023)

The future of cancer treatment using precision oncogenomics
por: Wartman, Lukas D.
Publicado: (2018)

Cardiovascular disease risk scores in identifying future frailty: the Whitehall II prospective cohort study
por: Bouillon, Kim, et al.
Publicado: (2013)

Inflammation, Insulin Resistance, and Type 2 Diabetes: Back to the Future?
por: Cefalu, William T.
Publicado: (2009)

Multinational Investigation of Fracture Risk with Antidepressant Use by Class, Drug, and Indication
por: Tamblyn, Robyn, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_olv9e3ammpvvk76f11ab7isbik